SBRT for Prostate Cancer

SBRT for Organ-Confined Prostate Cancer

A session from the 2016 RSS Webinar Series as presented by:

  • Alan J. Katz, MD, JD, Flushing Radiation Oncology Service, New York

This course is available from April 12, 2016 through 11:59 p.m. Eastern time on April 12, 2019. In order to earn credit for this course, participants must:

    • View the audio/slide presentation
    • Pass the five-question examination with a minimum of 70 percent, and
    • Complete the course evaluation.

The activity is approximately 1 hour in length.


Prostate cancer remains the most commonly diagnosed cancer, other than skin cancer, in men in the US, and is the second leading cause of cancer-related deaths in American men. The majority of prostate cancers are diagnosed at an early-stage, where treatment options including surgery, brachytherapy, external beam radiation therapy and active surveillance, all result in excellent local control and survival rates. Each of these treatment options have different urinary, bowel and sexual function side effects and treatment choice is often determined by evaluation of the toxicity profiles associated with the treatment.

Stereotactic body radiotherapy (SBRT), the ability to deliver high doses of radiation in a small number of fractions, is a relatively new (less than 10 years follow-up) treatment option for organ-confined prostate cancer, however studies from several institutions have shown excellent local control with minimal urinary, bowel and sexual function toxicities. Radiobiological studies also suggest an advantage of delivering high doses of radiation per fraction to treat prostate cancer. There is growing interest for the use of SBRT for the treatment of organ-confined prostate and a need to educate healthcare professionals on the rationale, growing body of published reports, treatment techniques, clinical outcomes , toxicity and quality of life after SBRT treatment of organ-confined prostate cancer. This webinar presented by Dr. Alan Katz, a leader in the field of prostate SBRT, will be discussing his 9-year experience treating prostate cancer patients with SBRT, including treatment techniques, clinical outcomes, toxicity and quality of life.


This program is designed to meet the needs of radiation oncologists with interests in the early prostate SBRT.


  • Identify candidates for SBRT for prostate cancer
  • Identify optimal dose
  • Recognize control and toxicity rates for all risk groups

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Amedco and the Radiosurgery Society® (RSS). Amedco is accredited by the ACCME to provide continuing medical education for physicians.


    AMEDCO designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


    • Non-Member: $10.00
    • RSS Member: Free (login to find the discount code)


    Software Requirements

    • A browser version of Internet Explorer 10.0 and higher or Firefox 3.0 or higher, Google Chrome Version 35 or higher

    A note on browser incompatibility:

    • We have tested IE 6.x in controlled configurations and we can stream successfully, but there are some versions that may not support the RTMP streams we push out - basically new technology that old technology can't handle.
    • Possible remedy: upgrade browser version, try alternate browsers such as Firefox.
    • Flash Player Version 11 or higher. If you have an older version it would be best to upgrade now. It's free and does not require a reboot.

    Hardware Requirements

    • Windows Based Computer, Mac based Computers, smart phone, tablets
    • Windows XP SP 3 or Vista Home Premium or better
    • Mac OS x 10.5.3 or better
    • Pentium 4 or better
    • 1meg of System Ram (Memory)
    • True Color 32 bit video card
    • Soundcard and speakers

    For more help with technical issues please click here.


    No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed on the RSS website under the title of the course.

    Participants using RSS online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

    The course and its materials will only be available on the RSS website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. The RSS reserves the right to remove a course before the end of its qualification period.

    Please contact if you have questions.

    Member login  

    the RSS would like to
    acknowledge and thank our 
    Corporate Sponsors.


    the RSS would like to 
    acknowledge and thank our 
    Academic & Hospital and
    Free-Standing & Private Practice

    the RSS is pleased to collaborate with the following:

    Interact With Us!
    facebook Like our Facebook Page   
    Join our Facebook Group
    twiter Follow us on Twitter 
    Follow our Group on LinkedIn
    Visit our Journal on Cureus
    Skype Me™!  Call us on Skype